NCT05817331View on ClinicalTrials.gov

Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia Questionnaire

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

June 28, 2022

Primary Completion Date

March 10, 2023

Study Completion Date

March 10, 2023

Conditions
Myelodysplastic Syndrome (MDS)
Interventions
OTHER

Carer Treatment Preference Myelodysplasia Questionnaire

Caregiver-reported outcome measure in MDS

OTHER

Clinician Treatment Preference Myelodysplasia Questionnaire

Clinician-reported outcome measure in MDS

OTHER

Patient Treatment Preference Myelodysplasia Questionnaire

Patient-reported outcome measure (PROM) in MDS

Trial Locations (1)

Unknown

Calvary Mater Newcastle, Newcastle

All Listed Sponsors
lead

Otsuka Australia Pharmaceutical Pty Ltd

INDUSTRY